ABCL - AbCellera Biologics GAAP EPS of -$0.10 beats by $0.03 revenue of $6.6M misses by $4.88M
2023-11-02 16:38:09 ET
More on AbCellera Biologics
- AbCellera's Clinical Carousel: High Risk, Higher Stakes
- AbCellera Biologics Q3 2023 Earnings Preview
- AbCellera expands its multi-target collaboration with Regeneron
- Seeking Alpha’s Quant Rating on AbCellera Biologics
- Historical earnings data for AbCellera Biologics
For further details see:
AbCellera Biologics GAAP EPS of -$0.10 beats by $0.03, revenue of $6.6M misses by $4.88M